Fundz

Circio Holding ASA secures NOK300m (€27m) in a private placement to accelerate development of its circular RNA platform and move its gene therapy programme towards clinical proof-of-concept.

PRIVATEJun 10, 2026

Amount Raised

NOK300 Million

Round Type

Post-IPO Equity

BiotechnologyHealth CareGeneticsTherapeutics

Description

Circio Holding ASA has completed a NOK300m financing package, including warrants and a private placement, bringing its total capital raised in H1 2026 to approximately NOK620m. The new funds will support the preclinical development of its circVec technology and accelerate a lead gene therapy programme. More than 400 subscribers participated, including existing shareholders and management. This funding is transformative for Circio as it pursues its goal to become an international biotech leader.

Quick answer

Circio Holding ASA raised NOK300 Million in a Post-IPO Equity round, dated June 10, 2026.

How much did Circio Holding ASA raise?
Circio Holding ASA raised NOK300 Million in a Post-IPO Equity round on June 10, 2026.
What does Circio Holding ASA do?
Circio Holding ASA is a biotechnology company focused on developing innovative circular RNA expression technology for gene and cell therapy.
Who are the decision-makers at Circio Holding ASA?
Fundz holds 2 contacts at Circio Holding ASA, including the Chief Financial Officer and Chief Business Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Genetics and Therapeutics around the same time

Companies in the same sectors as Circio Holding ASA that raised within 45 days of this round, from Fundz verified event records.

  • Definium Therapeutics raised $805M (Post-IPO Equity) on July 24, 2026.
  • Scancell Holdings PLC raised $39M (Post-IPO Equity) on July 23, 2026.
  • Mentari Therapeutics raised $200M (Post-IPO Equity) on July 22, 2026.
  • Tikva Allocell Pte. Ltd raised $8M (Series A) on July 22, 2026.
  • Transcripta Bio raised $24M (Series A) on July 22, 2026.
  • Brenus raised $13M (Series A) on July 21, 2026.

Who to call at Circio Holding ASA, and when

A new round usually means Circio Holding ASA is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Circio Holding ASA raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Circio Holding ASA, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Circio Holding ASA. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Circio Holding ASA

About

Circio Holding ASA is a biotechnology company focused on developing innovative circular RNA expression technology for gene and cell therapy. Their unique approach aims to enhance gene expression while ensuring safety and efficacy in therapeutic applications. Circio is dedicated to addressing unmet medical needs through advanced genetic solutions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Circio Holding ASA raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsLubor G., Chief Financial Officer and Chief Busin… hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Circio Holding ASA's next move

See what Strategic adds

Circio Holding ASA raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.